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ABSTRACT We hypothesized that performance and
bone mineralization of 2 broiler lines will benefit from
increasing vitamin D (vitD) supplementation above
current commercial levels and by partial substitution
of D3 by 25-OH-D3. Male Ross 308 and 708 chicks (n =
576), were offered diets with low (LD; 1,000), medium
(MD; 4,000) or high levels of D3 (HD; 7,000 IU/kg),
and medium levels of vitD where the majority of D3 was
substituted by 25-OH-D3 (25MD; 1,000 D3+3,000 25-
OH-D3 IU/kg). Performance was measured at the end
of starter (day 10), grower (day 24), and finisher periods
(day 38). Three birds per pen were dissected at the end
of each period to assess tibia and femur ash percent-
age (%), ash weight, bone breaking strength (BBS),
and serum levels of 25-OH-D3. Remaining birds were
gait scored (GS) at day 37 of age. Genotype and diet
did not interact for any trait, whilst performance was
not affected by diet. Ross 708 had lower body weight
(P < 0.005), higher feed conversion ratio over the
grower period (P < 0.05), similar levels of 25-OH-D3,
but higher GS (P < 0.05) than Ross 308. Serum 25-
OH-D3 levels were affected by diet at the end of the
starter and grower periods (P < 0.05), being lowest
for LD and highest for 25MD. Diet affected GS (P <
0.01), being higher in LD than 25MD. Femur ash % was
higher at the end of the starter and grower periods for
25MD than LD and for both HD and 25MD than LD
(P < 0.05). Femur and tibia ash weight were higher for
25MD in comparison to LD birds (P < 0.05) at the end
of the grower period. Femur and tibia BBS were higher
(P < 0.05) for 25MD in comparison to LD at the end
of the grower and finisher periods, respectively. Over-
all, effects of vitD supply were more pronounced for
femur than for tibia mineralization. Results do not sug-
gest supplementation of vitD above current maximum
levels and support partial substitution by 25-OH-D3.
Key words: vitamin D, 25-OH-D3, broiler, growth rate, bone mineralization
2018 Poultry Science 0:1–11
http://dx.doi.org/10.3382/ps/pey350
INTRODUCTION
Genetic selection of broiler chickens has amongst
other characteristics improved substantially growth
rate and feed conversion ratio (FCR) (Siegel, 2014),
and has shifted focus towards breast muscle rather than
leg muscle yield, moving the center of gravity of the
bird forward (Corr et al., 2003a). Higher growth rates
have been suggested as a cause for the increasing occur-
rence of skeletal abnormalities of the locomotory sys-
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tem observed in broilers (Kestin et al., 2001; Williams
et al., 2004), although genetic selection for improving
leg health may reduce their incidence, despite some-
what unfavorable genetic correlations with growth rates
(Kapell et al., 2012).
Vitamin D (vitD) is involved in skeletal integrity
through the stimulation of the expression of genes
in the small intestine which govern intestinal cal-
cium and phosphorus absorption, in bone to osteo-
clast differentiation and calcium reabsorption promot-
ing mineralization of the bone matrix (St-Arnaud,
2008). It can either be produced in the skin by the
photochemical conversion of the provitamins ergos-
terol and 7-dehydrocholesterol to cholecalciferol (D3)
or absorbed from the diet in the intestinal tract.
D3 is hydroxylated to 25-hydroxycholecalciferol (25-
OH-D3) primarily in the liver and is circulated by
the vitD binding protein (Haussler et al., 2013).
This form is further hydroxylated in the kidneys,
but also in the intestine, to the hormonally ac-
tive form, 1α,25-dihydroxycholecalciferol (1,25-OH-D3)
(Fleet and Schoch, 2010). The use of windowless
houses in conventional broiler farms does not allow
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the skin to produce endogenous vitD, whilst raw
materials in broiler diets contain little or no vitD
(Atencio et al., 2005). As a result requirements are
covered by means of dietary supplementation only
(Waldenstedt, 2006). It has been demonstrated that
dietary 25-OH-D3 is absorbed more efficiently than
D3 in the upper portion of the intestine of broilers
(Bar et al., 1980). At comparable levels of D3, the
25-OH-D3 isomer has been generally shown to im-
prove performance and skeletal health (Cantor and
Bacon, 1978; Fritts and Waldroup, 2003; Yarger et al.,
1995b).
Historically, inclusion levels of vitD at a commer-
cial level far exceed what is typically reported as
the requirement by the NRC (200 IU/kg of feed)
(Applegate and Angel, 2014). The latter, however,
are based on old type, slower growing birds, whilst
the current legal dietary limit in the European Union
is 5,000 IU/kg feed. The basis for establishment of
the upper limit is rather ambiguous and does not
take into account bird genetic improvement; previ-
ous studies indicate adverse effects on performance,
bone ash and renal calcification at levels of supple-
mentation levels above 20,000 IU/kg (Baker et al.,
1998; Browning and Cowieson, 2014; Yarger et al.,
1995a). In commercial practice, dietary inclusion lev-
els range between 2,000 and 5,000 IU/kg of feed
(Whitehead et al., 2004; Leeson, 2007). In legislation
there is no distinction about the form of vitD that can
be added in the diet, whilst the European Food Safety
Authority prohibits its addition to water (European
Food Safety, 2009).
The objective of the present study was to re-evaluate
the vitD requirements of 2 modern growing modern
broiler genotypes offered Ca and P adequate diets. We
hypothesized that at increasing levels, beyond the cur-
rent legal limits, vitD supplementation of fast growing
broilers will lead to improved skeletal integrity as mea-
sured by bone breaking strength (BBS), long bone min-
eralization, and better walking capacity. Furthermore,
effects on bone mineralization were expected to be more
pronounced at initial stages of growth when mineraliza-
tion of the skeleton occurs most rapidly (Angel, 2007;
Talaty et al., 2009). In addition, we hypothesized that
if legal dietary maximum levels are to be maintained,
partial substitution of D3 by 25-OH-D3 will be benefi-
cial for bird skeletal integrity.
MATERIAL AND METHODS
Birds, Husbandry and Diets
All procedures were conducted under the UK An-
imals (Scientific Procedures) Act 1986 and were ap-
proved by the Animal Welfare and Ethical Review Body
(AWERB) of Newcastle University. The trial was con-
ducted in 2 rounds with an 8-wk interval. For each
round, 144 male Ross 308 chicks and 144 male Ross 708
d old chicks were obtained from a commercial hatchery,
vaccinated against avian infectious bronchitis virus (576
in total). Ross 308 is one of the most commonly used
modern growing genotypes. Ross 708 is also a modern
growing genotype, albeit displaying inferior FCR and
ADG during the starter and grower period, commonly
used in roaster market and is selected for high breast
muscle yield. The same flocks of origin were used for
both rounds, and were of 32 and 40 wk of age for the
Ross 308 flock and of 36 and 44 wk of age for the Ross
708 flock, during the first and the second round respec-
tively.
Birds were housed in a windowless thermostatically
controlled building in 24 circular pens with a diame-
ter of 1.2 m (1.13 m2), at an initial stocking density
of 12 birds/pen. Pens were equipped with tube feed-
ers and bell-drinkers and wood shavings were used as
litter to a depth of 5 cm. Birds had ad libitum access
to feed and water throughout the trial. Heat was sup-
plemented with dull emitter ceramic bulbs. Tempera-
ture at pen level was monitored daily and maintained
to meet Aviagen recommendations for spot brooding
(Aviagen, 2014b), starting at 34◦C at chick placement
and gradually reduced to 21◦C by 27 d, where it was
maintained until 39 d of age when the trial was ter-
minated. Light intensity at pen level was 80 lx whilst
a lighting schedule of 23L:1D was applied for the first
7 d of age switched to 18L:6D for the remainder of the
trial. All birds were individually wing-tagged at day 2
post-hatch.
A basal starter (day 1 to 10) grower (day 11 to 24)
and finisher (day 25 to 39) diet were manufactured
according to nutrition specifications (Aviagen, 2014a)
apart from level and source of vitD (see below). The
starter diet was offered in crumbled form and the grower
and finisher diets in pelleted form (Table 1).
Experimental Design
The experiment was 4 × 2 × 2 factorial design
with dietary treatment, genotype, and round as the
independent variables. Upon arrival, day old chicks of
each of the Ross 308 and 708 genotypes were randomly
allocated to 1 of 4 dietary treatments: a diet offering
low level of D3 (LD; 1,000 IU/kg) which aimed at in-
ducing a marginal vitD deficiency (Fritts et al., 2003), a
diet offering medium level of D3, close to what is used
in commercial practice (MD, 4,000 IU/kg), a diet of-
fering high levels of D3, which is above the European
Union legal limit of 5,000 IU/kg (HD; 7,000 IU/kg D3)
and a diet offering the medium level of vitamin D3,
where the majority of D3 was substituted by 25-OH-D3
(25MD; 1,000 D3+3,000 25-OH-D3 IU/kg). Each treat-
ment (genotype × diet) had 3 replicate pens for each
experimental round. Three birds per pen were selected
based on their wing tag, 2 of which were sampled on day
10, day 24, and day 38 and 1 on day 11, day 25, and day
39. Pen body weight (BW) was measured at placement
and pen FI and individual bird BW was measured at
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Table 1. Ingredient and analyzed chemical composition of the
basal starter (day 1 to day 10 post-hatch), grower (day 11 to day
24 post-hatch), and finisher (day 25 to day 39 post-hatch) diets
offered to the birds.
Item Starter Grower Finisher
Ingredient (%)
Wheat 47.8 51.5 54.8
Soybean meal (48% CP) 32.1 25.3 18.7
Corn 10 10 10
Full fat soybean 4.0 7.0 10
Dicalcium phosphate 1.90 1.66 1.46
Soy oil 1.84 2.32 2.86
Limestone 0.64 0.59 0.54
Vitamin and mineral premix1 0.4 0.4 0.4
DL-methionine 0.33 0.30 0.27
L-Lysine 0.27 0.25 0.23
Sodium bicarbonate (27%) 0.21 0.20 0.19
Sodium chloride (39%) 0.20 0.21 0.21
L-Threonine 0.15 0.12 0.10
Coccidiostat 0.07 0.07 0.06
Choline chloride (60%) 0.05 0.05 0.05
L-Valine 0.03 0.02 0.02
Xylanase3 0.02 0.02 0.01
Nutrient composition (%)2
ME (kcal/kg) (calculated) 3,000 3,100 3,200
Crude protein 20.54 19.03 17.30
Ether extract 4.22 5.27 6.31
Calcium 0.93 0.84 0.83
Total phosphorus 0.74 0.70 0.66
Available phosphorus (calculated) 0.48 0.44 0.40
Sodium 0.16 0.16 0.17
Ash 5.23 4.78 4.37
1,2Provided per kilogram of feed vitamins, minerals, and digestible AA
according to Aviagen Nutrient specifications (Aviagen, 2014a).
3Ronozyme WX, DSM Nutritional Products Ltd.
day 2, day 10, day 24, and day 38 of age and on day 11,
day 25, and day 39 for birds dissected on those dates.
Blood Sampling and Serum Levels of
25-OH-D3
The selected birds were individually weighed be-
fore blood-sampling via the wing vein and were sub-
sequently euthanized with a lethal injection of sodium
barbiturate (Euthatal, Merial Harlow, United King-
dom). Blood was placed in 5 mL serum tubes with
serum clot activator, gel separator (BD Vacutainer,
SST II Advance Plus Blood Collection Tubes—BD,
Plymouth, United-Kingdom). Samples were allowed to
clot for 1.5 h at room temperature and serum was col-
lected, following centrifugation for 5 min at 1,300 × g
in Eppendorf tubes and stored at −20◦C pending anal-
yses for serum levels of 25-OH-D3 using a commercially
available ELISA kit specifically designed for chicken
serum or plasma (MyBioSource, San Diego, CA).
Bone Measurements
Following euthanasia the right tibia and femur
were immediately dissected, defleshed, and stored in
polystyrene air tight sealed bags at −20◦C. Bones
were thawed at 4◦C in a walk-in fridge overnight and
tibia and femur length and diameter at the center of
the diaphysis were measured with digital callipers.
Bones were subjected to a 3-point break test using an
Instron testing machine (Instron 3340 Series, Single
Column-Bluehill, Fareham Hants, UK). The testing
support consisted of an adjustable 2-point block jig,
spaced at 30 mm for tibias and 20 mm for femurs for
the 10 and 11 d-old birds, and 30 mm for the older
birds. The crosshead descended at 5 mm/min until
a break was determined by measuring a reduction in
force of at least 5%.
Following breaking strength, bones were split in 2 and
the bone marrow was manually removed. Subsequently
bones were soaked in petroleum ether for 48 h for lipid
removal, were then placed in an oven at 105◦C for 24 h
and the dry bone weight was recorded. Samples were
then ashed for 24 h at 600◦C for the determination of
ash weight (g) and ash percentage (%).
In birds dissected at day 11, 25, and 39 of age, tibia
calcium and phosphorous ash content was measured
by an inductively coupled plasma (ICP) emission spec-
troscopic method. Calcium and phosphorous standard
for ICP (Fluka, Neu-Ulm, Switzerland) was prepared.
Ashed sample of 0.5 g was weighed in a 100 mL beaker
and 30 mL of 6 N HCl was added to each sample and
placed in a fume cupboard to digest for 18 h at room
temperature. Samples were then placed on a hot plate
(100◦C) in a fume cupboard and slowly brought to the
boil and digested for 30 min with 50% (6 M) hydrochlo-
ric. The samples were cooled and quantitatively trans-
ferred to a 250 mL volumetric flask. Beakers were rinsed
twice with 7 mL of 5% HCL to ensure complete trans-
fer. The final volume was made up to 250 mL with 1%
nitric acid solution. 1 mL of sample filtrate was pipet-
ted into a 50 mL centrifuge tube and made up to 50 mL
with 1% nitric acid solution. Samples were centrifuged
at 1,500 rpm for 10 min at room temperature and in-
troduced to an ICP spectrometer equipped with a CCD
detector (ICP-OES; Varian Vista MPX, Varian, Palo
Alto, CA, USA) and measured at wavelength 317.933
for calcium (Ca) and 213 nm for phosphorus (P) against
prepared standards ranging from 1 to 100 ppm in cal-
cium and phosphorus content.
Gait Scoring
The remaining birds were individually assessed for
their walking capacity at 37 d of age, using the 0 to
5 gait scoring system of Kestin et al. (1992), where a
score of 0 represents a perfect gait and a score of 5
represents inability to stand. Briefly, gait score 0 (GS
0) describes a bird with no detectable gait abnormality;
GS 1 birds have a slight walking defect; GS 2 birds have
an identifiable defect; a GS 3 bird has an obvious gait
abnormality; GS 4 birds have a severe gait defect, only
walking when motivated. There were no birds with a GS
of 5 in the current trial. The wing tag of each bird was
noted and the bird was subsequently assessed by 3 in-
dependent observers, directly in their pens, after being
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herded away from the other birds. The score was then
discussed between observers and the bird was possibly
re-assessed until an agreement was reached.
Statistics
Pen was the experimental unit for all data acquired
at the end of starter, grower, and finisher period and
all analysis were carried with SAS software (SAS 9.3,
Cary, NC, USA). Femur and tibia ash % were aver-
aged per pen for the 3 birds dissected at the end of
each period. Tibia and femur dimensions (mm), and
ash weight (g) obtained from the 3 sampled birds per
pen at the end of each of the 3 periods were expressed
as a proportion of individual BW at dissection (kg) and
were then averaged per pen to account for differences in
growth between genotypes, rounds, and sampling days.
Expressing bone variables as a proportion of BW has
been previously used in studies comparing genotypes
differing in their growth potential (Shim et al., 2012).
Analyzed Ca and P expressed as a percentage of tibia
ash, Ca: P ratio and levels of 25-OH-D3 from 1 bird per
pen dissected at day 11, day 25, and day 39 were ana-
lyzed with bird representing the pen. Data were statis-
tically analyzed with the GLM procedure with dietary
treatment, genotype, and round as the main effects in-
cluding all 2-way and the 3-way interaction among and
between the main effects. For the analysis of average
pen BW and ADFI for the starter, grower and finisher
stages the average pen BW obtained at day 2 of birds
maintained until day 10, day 24, and day 38 post-hatch,
respectively, was used as a covariate respectively to ac-
count for differences in starting BW among treatments
and between rounds.
Initial analysis revealed the presence of round effects
attributed to the older age of the maternal flocks at
Round B, which resulted in a higher BW at placement
in round B in comparison to round A (43.98 ± 0.24 vs.
38.06 ± 0.16 respectively). However, there were no sig-
nificant interactions between round and the other fac-
tors for any of the measured variables. Therefore round
and its 2-way and 3-way interaction with genotype and
diet were excluded from the final model, which included
only genotype, diet, and their interaction. When signif-
icant differences were detected, treatment means were
separated and compared by the Tukey’s multiple com-
parison test. For assessing the normality of the resid-
uals the Shapiro–Wilk test was used. Significance was
determined at P < 0.05. Values are expressed as model
predicted means along with their pooled SEM.
Additional polynomial contrasts were performed to
study the linear and quadratic responses of bone vari-
ables and serum 25-OH-D3 levels to increased levels of
D3 (1,000, 4,000, and 7,000 IU/kg). Single degree of
freedom contrasts were carried to compare the 25MD
treatment with the MD and HD treatment and the MD
with the HD treatments, on bone variables and serum
25-OH-D3 levels.
RESULTS
Performance and GS
Both diet and its interaction with genotype did not
affect any of the performance variables. Main effects
of genotype and diet are presented in Table 2. Geno-
type significantly affected BW (P < 0.05) with birds
of the Ross 708 genotype achieving lower BW than the
Ross 308 at the end of the starter (P < 0.05), grower
(P < 0.01), and finisher period (P < 0.0001). At the
same time, they had significantly higher FCR during
the grower period (P < 0.05).
Genotype and diet did not interact for GS. Birds
of the Ross 708 genotype had significantly higher GS
(P < 0.05) than birds of the Ross 308 genotype. Diet
significantly affected GS (P < 0.01), with birds on
the LD treatment achieving significant higher GS than
birds on the 25MD treatment.
Bone Measurements
There was no significant interaction between geno-
type and dietary treatment on any of the bone vari-
ables tested. Main effects of genotype and diet of the
GLM model, as well as linear and quadratic effects and
contrasts on femur and tibia variables are presented in
Tables 3 and 4, respectively.
Genotype. Birds of the Ross 708 growing genotype
had significantly longer femurs per unit of BW (P <
0.01) at the end of the finisher period, which were sig-
nificantly wider at the end of the starter (P < 0.05) and
finisher periods (P < 0.01) in comparison to those of
the Ross 308 genotype. Tibias were significantly longer
(P < 0.001) per unit BW in birds of the Ross 708 geno-
type at the end of the finisher period than in Ross 308
birds. Tibia of birds of the Ross 708 line yielded less ash
weight at the end of the grower (P < 0.01) and finisher
periods (P < 0.01).
Diet. Femur ash weight was affected by diet (P <
0.05) at the end of the grower period, being signifi-
cantly higher (P < 0.05) for birds on the 25MD diet in
comparison to the LD treatment. Femur BBS was sig-
nificantly affected during the finisher period (P < 0.01),
being significantly higher for the 25MD in comparison
to LD birds (P < 0.05). Femur ash % was significantly
affected by diet at the end of the starter and grower pe-
riods; it was significantly higher (P < 0.05) for birds on
the 25MD than on the LD treatment (P < 0.05) and for
birds in both HD and 25MD treatments in comparison
to birds on the LD treatment (P < 0.05).
Tibia width was significantly affected by diet (P <
0.01), being significantly higher for both 25MD and
MD birds (P < 0.05) than LD birds at the end of the
grower period. Tibia ash weight was significantly af-
fected by diet (P < 0.05), being higher in 25MD birds
in comparison to LD birds at the end of the grower
period (P < 0.05) and tended to be affected at the
end of the finisher period being numerically higher for
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birds on the 25MD treatment. Tibia BBS was signif-
icantly affected (P < 0.05) at the end of the grower
period being higher for 25MD birds than LD birds
(P < 0.05).
Linear and Quadratic Effects and Contrasts. Sig-
nificant linear effects (P < 0.05) were obtained at the
end of the grower period for femur ash % and for
tibia ash weight, both increasing at increasing levels
of D3. A quadratic effect was obtained at the end of
the grower period for tibia width (P < 0.01) and at
the end of the finisher period for femur ash weight
(P < 0.05). Contrasts between MD and 25MD treat-
ments revealed that 25MD treatment resulted in signif-
icantly higher femur ash weight at the end of the finisher
period and tibia ash weight at the end of the grower
and finisher periods weight (P < 0.05). Similarly, higher
tibia BBS was achieved at the end of the grower period
for 25MD in comparison to the MD treatment weight
(P < 0.05). There was a significant linear effect of diet
on tibia Ca percentage on day 11, with its levels in-
creasing as vitD increased. However, no significant dif-
ferences were revealed when contrasting 25MD with HD
or MD with HD other than a significantly lower tibia
width for HD in comparison to both other treatments
(P < 0.05).
Serum 25-OH-D3
There was no significant effect of genotype and no
significant interaction between genotype and dietary
treatment on serum 25-OH-D3 levels of birds dissected
at day 11, day 25, and day 39 of age. Main effects of
genotype and diet of the GLM model, as well as lin-
ear and quadratic effects and contrasts, are presented
in Table 5. Dietary treatment significantly affected
(P < 0.001) serum 25-OH-D3 levels at both day 11 and
day 25 of age (P < 0.0001) (Table 5); the effect of di-
etary levels of D3 was linear, with increasing level of
D3 leading to increased serum 25-OH-D3 levels. 25MD
birds contained higher levels of serum 25-OH-D3 than
MD birds on d11 and d25.
DISCUSSION
In the present study we assessed the effects of vitD
supplementation by offering a diet with suboptimal lev-
els of D3 (LD), diets with levels close to commercial
recommendations where the additional vitD was offered
either as D3 (MD) or as 25-OH-D3 (25MD), and a diet
above commercially recommended levels, and European
Union allowed levels offered as D3 (HD). We hypothe-
sized that a linear increase of D3 supplementation levels
will result in higher skeletal integrity, as measured by
BBS, bone mineralization and better walking capac-
ity, which will be linked with higher levels of serum
25-OH-D3. In addition, we expected that partial sub-
stitution of D3 by 25-OH-D3 treatment at commercial
supplementation levels would affect measured variables
to a higher degree as it has been shown to be metabol-
ically more potent on a per unit basis than D3 (Fritts
et al., 2003). Linear effects of vitD supply in the form
of D3 were observed on the level of femur ash (%) and
tibia ash (g) at the end of the growing period. However,
contrary to our hypothesis, vitD supplementation levels
above 5,000 IU/kg (HD) in the form of D3 did not con-
fer substantial benefits on tibia and femur mineraliza-
tion in comparison to commercially used levels (MD).
Partial substitution of D3 by 25-OH-D3 at commercial
levels of supplementation leads to improved aspects of
long bone mineralization. Nonetheless, the majority of
dietary effects derived from the differences observed
between 25MD and LD treatment groups, the latter
Table 2. Main effect of genotype (Ross 308 or 708) and dietary treatments on body weight (BW), average daily feed intake (ADFI),
and feed conversion ratio (FCR) over the starter (day 1 to 10), grower (day 11 to 24), and finisher period (day 25 to 38) and on
gait score (GS) at day 37 of age. LS means of BW and ADFI are adjusted for BW at day 2 post-hatch (cvBW) which was used as a
covariate.
BW (g) ADFI (g) FCR GS
Day 10 Day 24 Day 38 Day 1 to 10 Day 11 to 24 Day 25 to 38 Day 1 to 10 Day 11 to 24 Day 25 to 38 Day 37
Genotype
Ross 308 334.8 1516.6 3349.8 36.2 109.9 200.0 1.23 1.30 1.53 1.97
Ross 708 329.2 1472.9 3201.7 36.2 108.8 192.8 1.25 1.33 1.56 2.24
SEM 1.5 9.9 24.4 0.3 1.1 2.6 0.01 0.01 0.02 0.09
Diet
LD 332.2 1518.2 3293.2 36.9 111.9 195.8 1.27 1.32 1.55 2.36a
MD 329.0 1475.8 3276.6 35.8 107.1 197.6 1.24 1.31 1.54 2.23a,b
HD 333.4 1501.5 3305.8 36.0 110.2 202.5 1.23 1.32 1.57 2.09a,b
25MD 333.5 1483.6 3227.5 35.9 108.3 189.8 1.23 1.32 1.52 1.72b
SEM 2.2 14.0 34.5 0.5 1.5 3.7 0.01 0.01 0.02 0.13
Source Probabilities
Genotype <0.01 <0.01 <0.001 0.988 0.542 0.101 0.078 <0.05 0.177 <0.05
Diet 0.120 0.763 0.607 0.390 0.293 0.113 0.101 0.911 0.510 <0.01
cvBW <0.001 <0.05 0.082 0.848 0.990 0.165 NA NA NA NA
a,bMeans in each column with different superscripts are significantly different (P < 0.05).
Abbreviations: LD (low level of D3; 1,000 IU/kg), MD (medium level of D3; 4,000 IU/kg), HD (high level of D3; 7,000 IU/kg D3), 25MD (medium
level consisting of 1,000 D3+3,000 25-OH- D3 IU/kg).
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Table 5. Main effect of genotype (Ross 308 or 708) and dietary treatments (GLM), linear, quadratic and single degree of freedom
contrasts on tibia calcium (Ca) and phosphorus (P) expressed as a proportion of bone ash, their ratio and serum levels of 25-OH-D3
at day 11, day 25, and day 39 post-hatch.
Variable Ca (% Ash) P (% Ash) Ca:P ratio 25-OH-D3 (ng/mL)
Day post-hatch Day 11 Day 25 Day 39 Day 11 Day 25 Day 39 Day 11 Day 25 Day 39 Day 11 Day 25 Day 39
Genotype
Ross 308 34.48 34.86 35.88 17.57 17.43 17.75 1.96 2.00 2.02 60.83 74.22 72.23
Ross 708 34.36 34.67 35.73 17.56 17.28 17.71 1.95 2.01 2.02 63.46 70.61 74.65
SEM 0.14 0.14 0.14 0.08 0.06 0.062 0.01 0.01 0.01 2.75 2.78 2.11
Diet
LD 33.99 34.83 35.89 17.52 17.43 17.86 1.94 2.00 2.01 47.60a 63.18a 69.80
MD 34.48 34.63 35.72 17.55 17.27 17.66 1.96 2.01 2.02 60.34a,b 72.34a,b 71.87
HD 34.51 34.80 35.55 17.57 17.35 17.65 1.96 2.01 2.01 67.48b 75.85b 74.92
25MD 34.71 34.80 36.08 17.63 17.37 17.75 1.96 2.00 2.03 73.17b 78.30b 77.19
SEM 0.20 0.19 0.20 0.11 0.09 0.09 0.01 0.01 0.01 3.90 3.94 2.99
Source Probabilities
Genotype 0.518 0.316 0.445 0.933 0.087 0.760 0.430 0.367 0.684 0.494 0.345 0.436
Diet 0.122 0.892 0.277 0.929 0.701 0.325 0.345 0.927 0.336 <0.001 <0.05 0.349
Contrasts
D3 level
Linear <0.05 0.910 0.252 0.769 0.574 0.132 0.262 0.549 0.726 <0.001 <0.05 0.241
Quadratic 0.278 0.464 0.996 0.979 0.327 0.455 0.385 0.781 0.345 0.494 0.552 0.897
MD vs. 25MD 0.461 0.610 0.217 0.636 0.523 0.613 0.805 0.915 0.915 <0.05 0.290 0.228
MD vs. HD 0.930 0.559 0.555 0.901 0.548 0.898 0.833 0.950 0.950 0.247 0.531 0.486
HD vs. 25MD 0.515 0.952 0.073 0.727 0.957 0.529 0.640 0.867 0.867 0.354 0.662 0.602
a,bMeans in each column with different superscripts are significantly different (P < 0.05).
Abbreviations: LD (low level of D3; 1,000 IU/kg), MD (medium level of D3; 4,000 IU/kg), HD (high level of D3; 7,000 IU/kg D3), 25MD (medium
level consisting of 1,000 D3+3,000 25-OH- D3 IU/kg).
leading to a state of marginal deficiency in regards to
bone mineralization according to hypothesis.
In the present study, performance was largely unaf-
fected by level or source of vitD supplementation. Al-
though, positive effects of vitD supplementation above
NRC recommendations are common (Baker et al., 1998;
Fritts and Waldroup, 2003; Whitehead et al., 2004; Rao
et al., 2006), the range at which effects are observed
and the nature of the parameters affected vary sub-
stantially amongst studies. Waldroup et al. (1965) were
the first to illustrate that vitD requirements vary ac-
cording to Ca and P dietary contents and their ratio.
The absence of a significant effect on performance in
our experiment, is possibly related to the adequate lev-
els of Ca and P which were supplemented in the diets,
as efficacy of vitD has been shown to be intrinsically re-
lated to their nutrient availability (Rennie et al., 1995;
Ledwaba and Roberson, 2003; Whitehead et al., 2004;
Rao et al., 2006, 2007, 2008). One would expect im-
proved performance in the 25MD treatment during the
starter period in comparison to the D3 treatments ow-
ing to the relatively fat independent absorption of 25-
OH-D3 as opposed to D3 (Sitrin and Bengoa, 1987;
Borel et al., 2015), and the limited ability of young
chicks to digest and absorb fat (Tancharoenrat et al.,
2013), but this was not supported by our findings.
In the absence of effects of our dietary treatments on
performance, femur, and to a lesser extent tibia, showed
generally increased mineral deposition (ash, g) and in-
creased mineralization (ash, %). These effects were ob-
served at the end of the starter and grower period for
femur, whilst effects only approached a tendency for
tibia. This is not surprising as increased mineraliza-
tion in the absence of effects on performance is com-
monly observed in response to supplementation with
Ca, and to a lesser extend P, as well as with vitD (Bar
et al., 2003; Angel et al., 2006). The majority of ab-
sorbed Ca and P is primarily required for bone forma-
tion (Adedokun and Adeola, 2013). An adequate level of
dietary Ca is essential for the bone deposition and
mineralization of P (Rousseau et al., 2012), whilst
rapid bone growth, requires adequate Ca and P sup-
ply (Williams et al., 2000b). VitD regulates calcium
and phosphorus metabolism mainly by enhancing in-
testinal calcium and phosphate absorption and renal
reabsorption whilst it also stimulates osteoclast differ-
entiation and calcium reabsorption from bone and pro-
motes mineralization of the bone matrix (St-Arnaud,
2008; Bikle, 2012; Haussler et al., 2013). It has been
estimated that during the initial stages of growth the
load applied to the skeleton due to a quadratic increase
in BW gain may be by as much as 32-fold imposing a
requirement for rapid skeletal adaptation (Yair et al.,
2012). The rate of growth and mineralization of the
skeleton occurs most rapidly during the first 2 wk of
age in the growing chick (Angel, 2007) and continues
until 4 wk of age, whereas after this period tibias grow
in length, width, and surface but this is not accom-
panied by increases in bone mineral density and bone
mineral content (Talaty et al., 2009).
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The stronger responses to dietary supplementation
with 25-OH-D3 and to increasing dietary levels of D3
at the end of the starter and grower periods on fe-
mur ash % are in accordance to the higher earlier
mineralization rate of the femur as compared to tibia
(Applegate and Lilburn, 2002) and are in agreement
with the suggestion that it is a better marker to assess
responses of dietary treatments on bone mineralization
(Angel et al., 2006). Dietary effects on other measure-
ments of skeletal integrity were less consistent; effects
on BBS were significant in the grower period for the
tibia but not on the femur. Surprisingly, there was an
effect of diet on femur BBS at the end of the finisher pe-
riod with 25MD diets having significantly higher BBS
than both LD and MD dietary treatments. This is con-
trary to our expectation as efficacy of the metabolites
should be reduced by the end of the finisher period as
it has been previously demonstrated that vitD supple-
mentation is more critical during the initial stages of
growth for bone development (Whitehead et al., 2004).
On the other hand, serum levels of 25-OH-D3 were re-
sponsive to the dietary treatments at the end of the
starter and grower stage, but absent by the end of the
finisher stage. One could interpret that there was a
state of adequacy at the later stages of growth, despite
the observed skeletal effects later in the finisher period
(Whitehead et al., 2004). However, it is contrary to con-
ventional expectation as circulating levels of 25-OH-D3
should increase more rapidly in response to 25-OH-D3
supplementation over time (Yarger et al., 1995b). In the
starter diets both 25MD and HD treatments had signif-
icantly higher values of 25-OH-D3 than LD, suggesting
that at least for the starter phase one could increase
D3 supplementation level above EU recommendations
in order to improve vitD adequacy. Therefore, dietary
treatment effects on ash weight as a proportion of BW
at the end of the finisher period are more likely a con-
sequence of higher levels of supplementation earlier in
the starter and grower periods.
In the present study vitD supplementation was as-
sociated with a lower GS in LD birds, in agreement
with Sun et al., (2013). Contrary to these findings,
Venalainen et al. (2006) did not find any effect of in-
creasing dietary Ca and P content on the walking ability
of broilers, although increased Ca and P supplementa-
tion affected tibia mineral deposition (Venalainen et al.,
2006). Even if the incidence of tibial dyschondroplasia
has been reduced in modern broiler populations (Kapell
et al., 2012), it is possible that development of tib-
ial dyschondroplasia may have been augmented by our
LD treatments as vitamin D supplementation has been
shown to reduce its prevalence (Elliot et al., 1995; Berry
et al., 1996; Rennie et al., 1995; Zhang et al., 1997;
Ledwaba et al., 2003). Furthermore, one cannot dis-
card the protective role that 25-OH-D3 has been shown
to exert in the development of bacterial chondronecro-
sis, which is considered the most prevalent cause of
lameness, in comparison to D3 (Wideman et al., 2015).
Therefore, a deterioration of GS in the LD treatment
may be linked to impaired bone long bone development
as indicated by the markers of mineralization, but also
to the incidence and severity of skeletal disorders al-
though these were not measured in the present study.
Higher growth rates have been associated with al-
tered Ca: P ratios in cortical bone (Williams et al.,
2000a) and at the same time altered Ca: P ratio has
been found in broiler bones suffering from leg patholo-
gies (Thorp and Waddington, 1997) although their con-
centration as components of hydroxyapatite is consid-
ered to be stable at a molar ration of 2:1 (Field, 2000).
It has been suggested that although bone ash % may be
decreased by low Ca or P diets, the Ca concentration
in ash still remains constant close to 37% whilst devia-
tions from this rule reflect differences in bone prepara-
tion and analysis (Field, 2000). However, in the present
study a reduced Ca percentage was observed at the end
of the starter period in LD birds, which nonetheless was
not associated with penalties on other markers of min-
eralization. More insight into the effects of vitD on Ca:
P ratio in reference to bone development may have been
gained had we focused on cortical bone samples rather
than the ash of both trabecular and cortical bone.
We hypothesized that reduced growth rates and feed
efficiency early in the starter period and grower period
would lead to reduced requirements of D3. When as-
sessing effects of genotype on growth rate, it should
be noted that birds performed significantly higher than
reported in the performance objectives (3223 and 3434
vs. 2472 and 2599, respectively at day 38 of age; Avi-
agen 2014c,d). In the present study birds of the Ross
308 showed increased BW at the end of the starter,
grower, and finisher periods according to expectations.
This was not accompanied by increases in ADFI. Ac-
cording to the performance objectives Ross 708 should
have displayed a higher initial FCR whilst differences
between genotypes should be smaller at the end of the
grower and finisher periods. In our study there was a
tendency for a lower FCR of Ross 308 at the starter pe-
riod whilst this difference was significant at the end of
the grower period. In terms of their skeletal traits Ross
708 displayed longer bones at the end of the finisher pe-
riod whilst femurs were wider. However, tibias carried
less ash weight as a proportion of BW at the end of the
grower and finisher periods. On the other hand, there
was a strong tendency (P = 0.055) for tibia ash % to be
higher at the end of the finisher period for Ross 708 in-
dicating that at older ages bones of this genotype may
be more mineralized. This genotype is maintained until
a later age and a higher degree of mineralization may
have resulted in better skeletal integrity at later stages
of growth. Despite observed differences in ash values,
BBS, which is indicative of the load bearing capacity of
the long bones (Rath et al., 2000) was ultimately sim-
ilar for both strains. The absence of genotype and diet
interactions indicates that subtle differences in growth
rate and FCR did not influence the requirements of the
2 genotypes in vitD. Previous research comparing the 2
genotypes has similarly shown that their requirements
for P are not significantly different (Persia and Saylor.,
2006). Although the GS of Ross 708 was inferior to
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that of Ross 308 broilers, the difference between the 2
genotypes was relatively small (1.97 vs. 2.23) and likely
reflects different selection objectives of the 2 genotypes
as Ross 708 is more heavily selected for breast mus-
cle. According to performance objectives at the slaugh-
ter weight achieved at the end of this study, Ross 708
has 1.7% of additional breast muscle in comparison to
the Ross 308 genotype whilst the weight of thigh is
similar and that of drumstick is reduced as a propor-
tion of the eviscerated carcass. It has been suggested
that the rapid growth of breast muscle moves the cen-
ter of gravity forward (Corr et al., 2003b). In a field
evaluation trial, birds of the same commercial line with
a higher GS, displayed differences in skeletal conformity
traits related to breast development such as different
breast angle (Skinner-Noble and Teeter, 2009). Finally,
studies assessing the effects of selection on locomotion
have clearly illustrated that differences in breast muscle
conformity traits have pronounced effects on locomo-
tion patterns and gait dynamics (Paxton et al., 2013,
2014). It is noteworthy that GS is a subjective method
of evaluation of the bird’s walking capacity and gait
patterns of the 2 genotypes were substantially differ-
ent; the Ross 708 has a wider stride which is in line
with the prevalence of more breast muscle. As a re-
sult it walks differently and tends to get a higher GS
(Sakkas, personal observation).
In conclusion, although dietary treatment effects on
performance were absent, offering a diet which included
25-OH-D3 led to consistent improvements in bone min-
eralization. These were seen as improvements in femur
and tibia ash content (per unit of BW) and BBS. The
effects were more obvious at the end of the grower pe-
riod (∼25 d of age) rather than at the end of starter and
finisher periods. The effects of the high vitamin D3 on
bone mineralization were less consistent and not statis-
tically different from either the effects of MD or 25MD.
It is possible that this was due to the statistical power of
our experiment. Our results do not suggest that current
maximum legal limits of dietary vitD inclusion need to
be re-evaluated.
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